- Chicago firm’s investment dates to ’07
- Arizona DME provider projects ~$30 mln in ’18 Ebitda
- BPOC invested in physician-staff provider Medicus in October
More than a decade into its investment, Chicago’s Beecken Petty O’Keefe & Co is exploring the sale of Preferred Homecare/Lifecare Solutions, Buyouts has learned.
Houlihan Lokey is providing financial advice to Preferred, the Mesa, Arizona, provider of respiratory-therapy products and services and other equipment to patients in their homes, sources familiar with the matter said.
Marketing materials were distributed in September, one of the sources said.
Preferred Homecare expects to produce 2018 Ebitda of about $30 million, this source said.
Preferred focuses largely on delivering in-home respiratory-therapy products and services tailored to individuals suffering from chronic obstructive pulmonary disease, congestive heart failure, sleep apnea, emphysema, and other conditions.
It also delivers home medical equipment and supplies including hospital beds and walkers, and it offers negative-pressure wound therapy, a treatment for chronic and acute wounds.
The company contracts with managed-care organizations, traditional health insurers, preferred-provider organizations, at-risk health providers, third-party administrators, self-insured plans and provider-network managers, among other providers.
Preferred employs more than 800 in over 20 locations, with a network of more than 50 clinicians throughout Arizona, Colorado and Nevada.
William Keys serves as CEO of Preferred, while Robert Fahlman is executive chairman.
BPOC purchased Preferred Homecare from Halifax Group in 2007.
In recent activity for BPOC, the healthcare-focused private equity firm in October invested in Medicus Healthcare Solutions, which helps healthcare providers recruit and staff physicians on a temporary basis.
Representatives of Beecken Petty couldn’t be reached, while those with Houlihan declined comment.
Action Item: Read more about trends in the durable medical equipment sector: https://bit.ly/2OijNb7